TGFBR1 and non-small cell lung carcinoma: In detail, Yang et al20 found that miR‐769‐5p was downregulated and associated with poor prognosis in NSCLC, and inhibited cell proliferation, migration, and invasion abilities via targeting TGFBR1 (transforming growth factor‐β1).